Αποτελέσματα Αναζήτησης
1 Οκτ 2019 · This document provides evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia. It covers 16 specific areas, such as diagnostic testing, site of care, empiric antibiotic therapy, and management decisions.
- Practice Guidelines
Guidelines. Practice Guidelines; Featured Guidelines....
- Practice Guidelines
15 Ιουλ 2020 · The ATS and IDSA guidelines on CAP diagnosis and treatment are reviewed and summarized by the AAFP. The guidelines cover illness severity criteria, diagnostic testing, antibiotic therapy, and treatment duration for CAP.
14 Αυγ 2018 · Knowledge of local bacterial pathogens and their antibiotic susceptibility and resistance profiles is the key for effective pharmacologic selection and treatment of pneumonia. Keywords: Pneumonia, Ventilator-associated, Community-acquired, Pediatric, Antibiotic resistance, Microbial pathogens. Key points. •.
We endorse the empiric treatment recommendations for MRSA and P. aeruginosa provided by the 2016 Clinical Practice Guideline from IDSA and ATS for the management of adults with hospital-acquired and ventilator-associated pneumonia .
Updated Guidelines for the Treatment of Community-Acquired Pneumonia. 1x. 0:00 / Subscribe to Podcast. CAP is an infection of the pulmonary parenchyma acquired outside of a health care setting. CAP is common, with more than 1.5 million adults hospitalized annually, and is the most common infectious cause of death in the US. 1.
In this guideline update, several key changes to evidence-based practice for pneumonia were made, including abandoning HCAP criteria to determine risk for resistant organisms, increasing the use of respiratory cultures, reducing the use of urinary antigen tests, preference of the PSI to guide hospitalization decisions, and avoiding macrolide ...
This document provides evidence-based recommendations on the diagnosis and treatment of adult patients with community-acquired pneumonia. It covers topics such as diagnostic testing, site of care, empiric antibiotic therapy, and management decisions based on risk factors and prognosis.
